Key result
Global screening campaign identifies hypertension in ~33% of adults, with low treatment and control rates.
Why the study?
May Measurement Month was initiated to raise awareness of the importance of blood pressure measurement and to address the shortfall in blood pressure screening programmes globally.
Cross-Sectional (n=4,214,663)
Yes
Answers are grounded in this paper and cite their sources.
Global opportunistic screening campaigns successfully identified nearly 1 million individuals with untreated or inadequately treated hypertension, highlighting significant gaps in worldwide blood pressure management.
The first May Measurement Month (MMM) campaign, a global blood pressure (BP) screening programme, began 2017 as an initiative of the International Society of Hypertension.1 Two subsequent annual campaigns have been completed in consecutive years2,3 and having had to defer activities due to the COVID-19 pandemic 2020 the fourth campaign was run in 2021, the results of which are currently in press. Since its initiation in 2017, volunteers from more than 100 countries have participated. aims of MMM have remained consistent from the start—to raise awareness of the importance of the measurement of BP at the individual and population level and to provide a temporary pragmatic solution to shortfall in BP screening programmes in countries around the world.
No takes yet. Share an insight, caveat, or question.
Poulter et al. (2022) conducted a cross-sectional in Hypertension (n=4,214,663). Opportunistic blood pressure screening was evaluated on Hypertension prevalence, treatment, and control rates.
Synapse has enriched 10 related papers. Consider them for comparative context: